Co-occurrence of targetable aberrations in non-small cell lung cancer patients harboring MAP2K1 mutations.

e20059Background: MAP2K1 mutations are rare in non-small cell lung cancer (NSCLC) and considered to be mutually exclusive with known driver mutations. Activation of the MEK1-cascade might play a pi...